PERRIGO Co plc 8-K

What Happened
Perrigo Company plc announced quarterly results for the three months ended March 28, 2026 in a press release dated May 6, 2026 (furnished as Exhibit 99.1 to the Form 8‑K). The company provided GAAP results along with a range of non‑GAAP and "Core" measures intended to reflect ongoing operating trends and the go‑forward business (excluding infant formula under strategic review and certain divestitures).

Key Details

• Filing date: May 6, 2026; Quarter ended: March 28, 2026; press release attached as Exhibit 99.1.
• Perrigo provided non‑GAAP measures such as adjusted gross profit, adjusted operating income, adjusted diluted EPS, adjusted gross/operating margins, constant‑currency net sales, and Core measures (Core net sales, Core organic net sales, Core diluted EPS, etc.).
• Non‑GAAP exclusions include amortization of acquired intangibles, unusual litigation, impairment charges, restructuring and termination benefits, loss on debt extinguishment, infant formula remediation, loss on divestitures and investments, and other adjustments.
• The company said it cannot reasonably reconcile certain FY2026 outlook items (e.g., “All In” or “Core” expected organic net sales growth, adjusted margins, adjusted EPS, or adjusted effective tax rate) to the most comparable GAAP measures due to unpredictable items such as non‑recurring infant formula charges, timing/amount of restructuring, and related tax effects.
• The Form 8‑K notes the furnished information is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly stated.

Why It Matters
For investors, Perrigo’s furnished release highlights both its reported Q1 results and the company’s preferred adjusted metrics for assessing underlying performance and the go‑forward business (Core). The extensive list of non‑GAAP adjustments and the company’s inability to reconcile certain FY2026 outlook metrics to GAAP underscore that forward non‑GAAP guidance may omit items that are uncertain in timing or amount (notably infant formula‑related and restructuring charges). Investors should review the attached press release and consider non‑GAAP/Core measures alongside the company’s GAAP statements to get a complete picture.